Explore 3 Stock Ideas & Industry Insights Download Free Report
Oxford Nanopore Technologies PLC shares rose 2.15% today to around 175.90p, as investors respond positively to the DNA and RNA sequencing specialist's progress in expanding beyond its core research customer base into higher-value clinical and biopharma applications.
Polar Capital Global Healthcare Trust plc shares rose 1.14% today to around 444.00p, as global healthcare equities staged a partial recovery after a period of relative underperformance against the broader market.
Syncona Limited shares rose 1.36% today to around 119.00p, as investors positioned ahead of a series of expected clinical and corporate catalysts across the life scienceInvestmenttrust's portfolio of gene and cell therapy companies.
The full-year 2025 results, for the year ended 31 December 2025 and reported on 26 March 2026, marked an important milestone. TotalRevenuerose 33% on a constant-currency basis to £170.9m, and the company reported operating EBITDA of £8.1m, against a £15.3m loss the prior year, …
The half-year 2026 results, for the six months ended 30 June 2026, showed steady progress. CoreRevenuerose 4% to $1,728m, core operating profit rose 9% to $405m at aMarginof 23.4%, up 90 basis points, and coreBasic Earnings Per Sharerose 5% to 128 cents, according to …
Allergy Therapeutics became a notable healthcare-sector mover on 21 September 2026, withLSE:AGY declining 8.65% to 4.75p.
Craneware plc became one of the most closely watched UK healthcare technology stocks on 21 September afterLSE:CRW fell 25.78% to 996p.
Covalon Technologies Ltd. (TSXV:COV) rose5.95% on September 21, 2026, extending investor attention around the company's improving financial performance and commercial expansion in medical technology.
DRI Healthcare stock rose4.96% on September 21, 2026, with the latest move coinciding directly with a significant new royaltyAcquisitionannouncement.
The full-year results for the year to 31 March 2026 continued a run of expansion.Revenuerose 11% to £31.6m, adjusted EBITDA increased 28% to £2.6m, and the company ended the year with cash of £11.1m, proposing aDividendof 6.3p, according to its reporting. This marked a …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…